<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet type="text/xsl" href="http://www.physorg.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0">
<channel>
<title>PHYSorg.com: PHYSorg news tagged with: adverse events</title>
<link>http://www.physorg.com/</link>
<language>en-us</language> 
<description>Physorg.com internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>New type of botulinum toxin appears to be well tolerated and may help reduce forehead wrinkles</title>
   	 <description>Injections with a new type of botulinum toxin appears to be well tolerated and may help to improve the appearance of moderate to severe forehead lines with no evidence of diminishing treatment response over 13 months, according to a report in the March/April issue of Archives of Facial Plastic Surgery, one of the JAMA/Archives journals.</description>
     <link>http://www.physorg.com/news156449859.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 16 Mar 2009 19:18:12 EST</pubDate>
	 <guid isPermaLink="false">news156449859</guid>
</item>
<item>
     <title>Deep brain stimulation treatment for advanced Parkinson's disease patients provides benefits</title>
   	 <description>Patients with advanced Parkinson disease (PD) who received deep brain stimulation treatment had more improvement in movement skills and quality of life after six months than patients who received other medical therapy, but also had a higher risk of a serious adverse events, according to a study in the January 7 issue of JAMA.</description>
     <link>http://www.physorg.com/news150483770.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 06 Jan 2009 17:02:50 EST</pubDate>
	 <guid isPermaLink="false">news150483770</guid>
</item>
<item>
     <title>Post-marketing studies finding adverse events in drugs used in children</title>
   	 <description>The Food and Drug Administration Modernization Act (FDAMA, 1997), designed to stimulate more drug safety studies in children, has resulted in more than 130 label changes since its inception nearly six years ago, according to researchers at Duke Children's Hospital. Their analysis appears in the September issue of Pediatrics.</description>
     <link>http://www.physorg.com/news139571480.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 02 Sep 2008 10:51:20 EST</pubDate>
	 <guid isPermaLink="false">news139571480</guid>
</item>


</channel>
</rss>

